Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types.A systematic pan-...
Κύριοι συγγραφείς: | Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
BioMed Central
2016
|
Παρόμοια τεκμήρια
-
The tumour hypoxia induced non-coding transcriptome.
ανά: Choudhry, H, κ.ά.
Έκδοση: (2016) -
Gene expression signatures as biomarkers of tumour hypoxia
ανά: Harris, B, κ.ά.
Έκδοση: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
ανά: Jubb, A, κ.ά.
Έκδοση: (2010) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
ανά: Harris, A, κ.ά.
Έκδοση: (2016) -
Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration
ανά: Laurent Schwartz, κ.ά.
Έκδοση: (2024-09-01)